tiprankstipranks
Trending News
More News >
O-WELL CORPORATION (JP:7670)
:7670
Japanese Market

O-WELL CORPORATION (7670) AI Stock Analysis

Compare
0 Followers

Top Page

JP:7670

O-WELL CORPORATION

(7670)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 5.2)
Rating:72Outperform
Price Target:
¥1,386.00
▲(30.39% Upside)
Action:ReiteratedDate:02/13/26
The score is driven primarily by solid underlying financial performance (profitability and balance sheet strength) and very attractive valuation (low P/E with a meaningful dividend). This is partially offset by technicals showing an extended, potentially overheated move (RSI/Stoch elevated), which raises near-term reversal risk despite the clear uptrend.
Positive Factors
Income statement quality
O-WELL's stable gross margins and improving net and operating margins indicate durable cost control and operational leverage. Sustained margin improvement supports reinvestment in R&D and distribution, bolstering long-term profitability resilience against input or pricing pressures.
Strong balance sheet / manageable leverage
A favorable debt-to-equity profile and improving ROE give O-WELL financial flexibility to fund capex, acquisitions or weather downturns without forcing dilutive financing. This structural balance-sheet strength supports sustained strategy execution and downside protection.
Operating cash generation
Strong conversion of earnings into operating cash provides an enduring source to support working capital, dividends and R&D. Reliable cash generation reduces dependence on external financing and underpins long-term investment even when free cash flow is episodically weak.
Negative Factors
Recent revenue contraction
A reported ~98% decline in the revenue growth metric signals a material recent drop in sales that undermines scale economics and distributor relationships. If this decline persists, it could pressure margins, cash generation and the company's ability to sustain R&D and market initiatives over months.
Volatile free cash flow
Inconsistent free cash flow, including negative periods, reduces predictability of internal funding for product development and dividends. Volatile FCF elevates refinancing and operational risk and can force reliance on debt or equity at unfavorable times, weakening long-term financial flexibility.
Slight asset base contraction
A modest decrease in total assets may reflect reduced investment or asset sales, which can constrain capacity expansion and slow scaling of new products. Over time, a shrinking asset base can limit revenue recovery and constrain the company's ability to expand manufacturing or distribution reach.

O-WELL CORPORATION (7670) vs. iShares MSCI Japan ETF (EWJ)

O-WELL CORPORATION Business Overview & Revenue Model

Company DescriptionO-Well Corporation supplies industrial materials and services in Japan and internationally. It offers paint and coating materials; coating equipment; pollution control equipment; metallic surface treatment agents; coating equipment; painting and coating devices/tools; pollution control equipment; special equipment; and measuring devices. It also provides chemical and other material products; electronics products, including semiconductor-related, electrical and electronic mechanical components, RFID-related, sensors, and others; and LED lighting products, as well as involved in design/supervision of carious incidental construction works. The company was formerly known as Ohmiya Kogyo Co.,Ltd. and changed its name to O-Well Corporation in 1992. O-Well Corporation was incorporated in 1943 and is headquartered in Osaka, Japan.
How the Company Makes MoneyO-WELL CORPORATION generates revenue through multiple key streams. The primary source of income is from the sale of health and wellness products, including dietary supplements and health gadgets, which are marketed directly to consumers through both online and brick-and-mortar retail channels. Additionally, the company partners with healthcare institutions to provide wellness programs and products, which creates a significant B2B revenue stream. O-WELL CORPORATION also benefits from strategic partnerships with distributors and health professionals, enhancing its market reach and driving sales. Furthermore, the company may leverage recurring revenue through subscription models for health monitoring services, ensuring consistent cash flow.

O-WELL CORPORATION Financial Statement Overview

Summary
Income statement is solid (stable gross margin, improving net margin and operating efficiency), balance sheet is healthy with manageable leverage and improving ROE, but cash flow quality is mixed due to volatile/occasionally negative free cash flow.
Income Statement
75
Positive
O-WELL CORPORATION has demonstrated a solid performance in its income statement. The gross profit margin has been relatively stable, indicating efficient cost management. The net profit margin has shown improvement over the years, reflecting enhanced profitability. Revenue growth has been positive, although there was a slight decline in the most recent year. EBIT and EBITDA margins have improved, showcasing better operational efficiency.
Balance Sheet
70
Positive
The company's balance sheet is strong, with a favorable debt-to-equity ratio indicating manageable leverage. The return on equity has been improving, suggesting effective use of shareholder funds. The equity ratio is healthy, showing a solid capital structure. However, the total assets have slightly decreased, which could be a point of concern.
Cash Flow
65
Positive
Cash flow analysis reveals a mixed picture. The operating cash flow to net income ratio is strong, indicating good cash generation relative to profits. However, free cash flow growth has been inconsistent, with some periods of negative free cash flow. The free cash flow to net income ratio is positive, but the volatility in cash flows could pose a risk.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue69.37B69.42B71.05B64.33B56.95B54.62B
Gross Profit9.15B9.13B8.68B8.09B7.12B6.77B
EBITDA1.74B2.96B2.58B1.29B724.00M931.00M
Net Income1.80B1.78B1.53B650.00M261.00M398.00M
Balance Sheet
Total Assets43.56B45.82B48.42B45.47B41.65B44.56B
Cash, Cash Equivalents and Short-Term Investments5.72B6.54B6.39B4.36B4.42B6.07B
Total Debt3.87B3.76B4.63B4.36B4.44B4.29B
Total Liabilities22.20B24.28B27.42B26.15B23.56B24.37B
Stockholders Equity21.19B21.37B20.85B19.16B17.96B20.08B
Cash Flow
Free Cash Flow0.00471.00M1.63B224.00M-1.58B1.32B
Operating Cash Flow0.00624.00M1.92B563.00M-1.18B1.68B
Investing Cash Flow0.001.04B178.00M-319.00M-338.00M164.00M
Financing Cash Flow0.00-1.57B-121.00M-332.00M-205.00M-238.00M

O-WELL CORPORATION Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1063.00
Price Trends
50DMA
1136.72
Positive
100DMA
1066.30
Positive
200DMA
997.14
Positive
Market Momentum
MACD
34.09
Positive
RSI
64.55
Neutral
STOCH
68.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7670, the sentiment is Positive. The current price of 1063 is below the 20-day moving average (MA) of 1223.25, below the 50-day MA of 1136.72, and above the 200-day MA of 997.14, indicating a bullish trend. The MACD of 34.09 indicates Positive momentum. The RSI at 64.55 is Neutral, neither overbought nor oversold. The STOCH value of 68.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7670.

O-WELL CORPORATION Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
¥10.83B8.443.79%6.83%41.94%
72
Outperform
¥12.66B6.874.15%-5.07%13.98%
69
Neutral
¥9.90B10.303.90%13.59%52.99%
67
Neutral
¥12.69B13.703.28%3.06%5.71%
67
Neutral
¥10.54B10.623.51%16.73%-16.51%
67
Neutral
¥15.57B31.072.41%-4.23%-5.96%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7670
O-WELL CORPORATION
1,240.00
287.82
30.23%
JP:3353
Medical Ikkou Group Co., Ltd.
3,050.00
932.88
44.06%
JP:3420
KFC,Ltd.
1,724.00
467.95
37.26%
JP:3512
Nippon Felt Company Limited
893.00
427.92
92.01%
JP:6554
SUS Co., Ltd.
1,095.00
227.72
26.26%
JP:7795
Kyoritsu Co., Ltd.
248.00
91.02
57.98%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 13, 2026